Full-gene haplotypes refine CYP2D6 metabolizer phenotype inferences
- 26 October 2017
- journal article
- research article
- Published by Springer Nature in International journal of legal medicine
- Vol. 132 (4) , 1007-1024
Abstract
CYP2D6 is a critical pharmacogenetic target, and polymorphisms in the gene region are commonly used to infer enzyme activity score and predict resulting metabolizer phenotype: poor, intermediate, extensive/normal, or ultrarapid which can be useful in determining cause and/or manner of death in some autopsies. Current genotyping approaches are incapable of identifying novel and/or rare variants, so CYP2D6 star allele definitions are limited to polymorphisms known a priori. While useful for most predictions, recent studies using massively parallel sequencing data have identified additional polymorphisms in CYP2D6 that are predicted to alter enzyme function but are not considered in current star allele nomenclature. The 1000 Genomes Project data were used to produce full-gene haplotypes, describe their distribution in super-populations, and predict enzyme activity scores. Full-gene haplotypes generated lower activity scores than current approaches due to inclusion of additional damaging polymorphisms in the star allele. These findings are critical for clinical implementation of metabolizer phenotype prediction because a fraction of the population may be incorrectly considered normal metabolizers but actually may be poor or intermediate metabolizers.Keywords
This publication has 45 references indexed in Scilit:
- Predicting the Functional Effect of Amino Acid Substitutions and IndelsPLOS ONE, 2012
- A method and server for predicting damaging missense mutationsNature Methods, 2010
- Opioid MetabolismMayo Clinic Proceedings, 2009
- Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithmNature Protocols, 2009
- Genetic markers and population history: Finland revisitedEuropean Journal of Human Genetics, 2009
- Human Splicing Finder: an online bioinformatics tool to predict splicing signalsNucleic Acids Research, 2009
- Functional Characterization of 17 CYP2D6 Allelic Variants (CYP2D6.2, 10, 14A–B, 18, 27, 36, 39, 47–51, 53–55, and 57)Drug Metabolism and Disposition, 2008
- Technology platforms for pharmacogenomic diagnostic assaysNature Reviews Drug Discovery, 2004
- Human Population Genetics: Lessons from FinlandAnnual Review of Genomics and Human Genetics, 2001
- Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolutionPharmacogenetics, 1997